Veeva Systems EBITDA 2012-2025 | VEEV
Veeva Systems annual and quarterly EBITDA history from 2012 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Veeva Systems EBITDA for the quarter ending April 30, 2025 was $0.245B, a 51.96% increase year-over-year.
- Veeva Systems EBITDA for the twelve months ending April 30, 2025 was $0.806B, a 48.06% increase year-over-year.
- Veeva Systems 2025 annual EBITDA was $0.722B, a 59.14% increase from 2024.
- Veeva Systems 2024 annual EBITDA was $0.454B, a 10.47% decline from 2023.
- Veeva Systems 2023 annual EBITDA was $0.507B, a 10.36% decline from 2022.
| Veeva Systems Annual EBITDA (Millions of US $) |
|
|---|---|
| 2025 | $722 |
| 2024 | $454 |
| 2023 | $507 |
| 2022 | $565 |
| 2021 | $431 |
| 2020 | $323 |
| 2019 | $253 |
| 2018 | $190 |
| 2017 | $151 |
| 2016 | $90 |
| 2015 | $76 |
| 2014 | $42 |
| 2013 | $31 |
| 2012 | $7 |
| 2011 | $5 |
| Veeva Systems Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-04-30 | $245 |
| 2025-01-31 | $198 |
| 2024-10-31 | $189 |
| 2024-07-31 | $173 |
| 2024-04-30 | $161 |
| 2024-01-31 | $142 |
| 2023-10-31 | $132 |
| 2023-07-31 | $109 |
| 2023-04-30 | $71 |
| 2023-01-31 | $119 |
| 2022-10-31 | $132 |
| 2022-07-31 | $114 |
| 2022-04-30 | $142 |
| 2022-01-31 | $135 |
| 2021-10-31 | $148 |
| 2021-07-31 | $140 |
| 2021-04-30 | $143 |
| 2021-01-31 | $112 |
| 2020-10-31 | $115 |
| 2020-07-31 | $103 |
| 2020-04-30 | $100 |
| 2020-01-31 | $74 |
| 2019-10-31 | $89 |
| 2019-07-31 | $81 |
| 2019-04-30 | $79 |
| 2019-01-31 | $70 |
| 2018-10-31 | $70 |
| 2018-07-31 | $61 |
| 2018-04-30 | $52 |
| 2018-01-31 | $47 |
| 2017-10-31 | $51 |
| 2017-07-31 | $46 |
| 2017-04-30 | $47 |
| 2017-01-31 | $63 |
| 2016-10-31 | $38 |
| 2016-07-31 | $28 |
| 2016-04-30 | $22 |
| 2016-01-31 | $19 |
| 2015-10-31 | $23 |
| 2015-07-31 | $24 |
| 2015-04-30 | $23 |
| 2015-01-31 | $23 |
| 2014-10-31 | $22 |
| 2014-07-31 | $18 |
| 2014-04-30 | $14 |
| 2014-01-31 | $12 |
| 2013-10-31 | $11 |
| 2013-07-31 | $10 |
| 2013-04-30 | $9 |
| 2013-01-31 | |
| 2012-10-31 | $9 |
| 2012-01-31 | |
| 2011-01-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $46.104B | $2.747B |
| Veeva Systems Inc. offers cloud-based software applications and data solutions for the life sciences industry. The company's product portfolio includes Veeva CRM (customer relationship management), Veeva Vault (content and information management), Veeva Network (customer master and product data management) and Veeva data services (Veeva OpenData and Veeva KOL data). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Doximity (DOCS) | United States | $12.505B | 55.48 |
| Hims & Hers Health (HIMS) | United States | $11.626B | 96.18 |
| Tempus AI (TEM) | United States | $10.538B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $5.092B | 0.00 |
| Hinge Health (HNGE) | United States | $4.422B | 0.00 |
| Privia Health (PRVA) | United States | $2.526B | 187.09 |
| Inspire Medical Systems (INSP) | United States | $2.341B | 34.41 |
| Enovis (ENOV) | United States | $1.626B | 8.59 |
| Phreesia (PHR) | United States | $1.607B | 0.00 |
| 10x Genomics (TXG) | United States | $1.513B | 0.00 |
| Omnicell (OMCL) | United States | $1.416B | 27.28 |
| Schrodinger (SDGR) | United States | $1.410B | 0.00 |
| Azenta (AZTA) | United States | $1.331B | 58.06 |
| Clover Health Investments (CLOV) | United States | $1.109B | 0.00 |
| Evolent Health (EVH) | United States | $1.057B | 0.00 |
| Claritev (CTEV) | United States | $0.934B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.623B | 0.00 |
| Veradigm (MDRX) | United States | $0.514B | 0.00 |
| Standard BioTools (LAB) | United States | $0.496B | 0.00 |
| Talkspace (TALK) | United States | $0.418B | 125.00 |
| Zepp Health (ZEPP) | Netherlands | $0.360B | 0.00 |
| Carlsmed (CARL) | $0.337B | 0.00 | |
| Butterfly Network (BFLY) | United States | $0.335B | 0.00 |
| TruBridge (TBRG) | United States | $0.284B | 49.76 |
| Nyxoah SA (NYXH) | Belgium | $0.253B | 0.00 |
| Outset Medical (OM) | United States | $0.227B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.215B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.197B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.183B | 0.00 |
| CapsoVision (CV) | United States | $0.182B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.126B | 0.00 |
| American Well (AMWL) | United States | $0.114B | 0.00 |
| CareCloud (CCLD) | United States | $0.113B | 5.14 |
| EUDA Health Holdings (EUDA) | Singapore | $0.097B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.092B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.074B | 0.00 |
| Pulmonx (LUNG) | United States | $0.063B | 0.00 |
| 111 (YI) | China | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
| HeartBeam (BEAT) | United States | $0.033B | 0.00 |
| Zhongchao (ZCMD) | China | $0.024B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.021B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.020B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |